Brooks Labs spikes nearly 20%, breaches upper circuit

Brooks Laboratories zoomed nearly 20% during Wednesday’s trade on the BSE. The stock breached upper circuit at Rs 124.65 and witnessed a spurt in volume by more than 18.82 times.

Jul 19, 2017 12:07 IST India Infoline News Service

Bombay Stock Exchange Up
Brooks Laboratories zoomed nearly 20% during Wednesday’s trade on the BSE. The stock breached upper circuit at Rs 124.65 and witnessed a spurt in volume by more than 18.82 times.
 
The stock has attracted a traded volume of 6,18,708 shares and traded value of Rs 738.74 lakh. The company has hit its 52-week high of Rs 194.70 on November 1, 2016, and 52-week low of Rs 95.15 on May 13, 2017, respectively, on the NSE.
 
Brooks Laboratories Limited is a pharmaceutical manufacturing company. The company is engaged in manufacturing of drugs and pharmaceuticals. The company is a contract manufacturer for molecules in Injectables and Clavulanic Acid range in tablets and dry syrups.
 
Stock view:
 
Brooks Laboratories Ltd is currently trading at Rs 124.65, up by Rs 20.75 or 19.97% from its previous closing of Rs 103.9 on the BSE.
 
The scrip opened at Rs 105.6 and has touched a high and low of Rs 124.65 and Rs 105.5 respectively. So far 791975(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 168.21 crore.
 
The BSE group 'B' stock of face value Rs 10 has touched a 52 week high of Rs 194.4 on 01-Nov-2016 and a 52 week low of Rs 96 on 16-Aug-2016. Last one week high and low of the scrip stood at Rs 108.5 and Rs 101 respectively.
 
The promoters holding in the company stood at 60.62 % while Institutions and Non-Institutions held 0.24 % and 39.14 % respectively.
 
The stock is currently trading above its 200 DMA.

Related Story